Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Hepatitis C: Where Are We and Where Are We Going?
Link ID 1656
Title Hepatitis C: Where Are We and Where Are We Going?
Url http://www.medscape.com/viewarticle/567220?src=rss
Description Tram T. Tran, MD, provides insight into the latest trends in the treatment of hepatitis C, as framed by data presented at AASLD 2007.
Medscape Gastroenterology
Category Articles > Gastroenterology
Keywords
Date Dec 17, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Gastroenterology
1. Symbiosis Factor Prevents Colitis in Animal Model
  A polysaccharide produced by the common human symbiotic microbe Bacteroides fragilis, which is found in the gut, appears to protect against intestinal inflammatory disease in an experimental model, the results of an animal study suggest. Reuters Health Information
Category:   Articles > Gastroenterology


2. Clinical Trial: Renzapride Therapy for Constipation-Predominant Irritable Bowel Syndrome – Mul
  This study confirms the gastrointestinal prokinetic effects of renzparide.
Alimentary Pharmacology & Therapeutics
Category:   Articles > Gastroenterology


3. Does the Number of Lymph Nodes Examined Affect Survival in Colon Cancer?
  Commentary on a study on checking lymph nodes after colectomy published November 14, 2007 in the Journal of the American Medical Society.
Medscape General Surgery
Category:   Articles > Gastroenterology


4. Multistate Outbreak of Human Salmonella Traced to Tainted Dog Food
  Contaminated dry dog food was the source of an outbreak of Salmonella infections affecting individuals in 19 states, public health officials report in the Morbidity and Mortality Weekly Report for May 16. Reuters Health Information
Category:   Articles > Gastroenterology


5. Stop-And-Go Oxaliplatin Effective in Elderly Colon Cancer Patients
  Elderly patients with metastatic colon cancer, those between 76 and 80 years of age, have response and survival rates similar to their younger counterparts when given a treatment approach that includes stop-and-go oxaliplatin. Reuters Health Information
Category:   Articles > Gastroenterology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS